Klinične študije za Luskavica v Ohio
9 študij za Luskavica išče udeležence na lokacijah v Ohio.
Mesta v Ohio
Uradno besedilo študije (angleško)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigation Site, Mayfield Heights
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07013201Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT03816345A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Optima Research - Boardman, Boardman
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06857942Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencev
Starost 18–94 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06399432A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Apex Clinical Research Center - Canton, Canton
- Apex Clinical Research Center, Lorain
- Apex Clinical Research Center, Mayfield Heights
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50745, Columbus
- Ppp001 50202, Fairborn
- Ppp001 50733, Mayfield Heights
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07219420A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Mayfield Heights
Vključevanje udeležencevFaza 2
Starost 18–70 · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT07489885Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 4
Starost 18–89 · Vsi spoli · Posodobljeno 2. apr. 2026 · NCT05270733IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18–70 · Vsi spoli · Posodobljeno 29. jun. 2023 · NCT05883371Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.